Autres langues BlinkLab Limited

Actions

BB1

AU0000322851

Logiciels

Marché Fermé - Australian S.E. 08:14:57 21/08/2026			Varia. 5j.	Varia. 1 janv.
0,8850 ^AUD	-2,21%		+32,09%	+9,26%

05/08	L'étude cas-témoins européenne de BlinkLab sur le TDAH affiche une sensibilité et une spécificité élevées ; l'action bondit de 10 %	MT
31/07	BlinkLab Limited publie ses résultats annuels pour l'exercice clos le 30 juin 2026	CI

Autres langues

05/08	BlinkLab's ADHD European Case-Control Study Achieves High Sensitivity, Specificity Results; Shares Jump 10%
31/07	BlinkLab Limited Reports Earnings Results for the Full Year Ended June 30, 2026
14/07	BlinkLab Targeting Opportunities Beyond Flagship Autism Program
26/06	BlinkLab Says European ADHD Study Completes Participant Recruitment, Shares Fall 3%
18/06	BlinkLab Secures US Patent for Remote Neurobehavioral Testing Platform
16/06	BlinkLab to Collaborate on Ecuadorian Study on Autism, Sensorimotor Function, Nutrition in Children, Adolescents
19/05	BlinkLab Enters Academic Research Agreement With Dutch Research Center
16/04	BlinkLab Generates Nearly AU$18 Million From Share Placement; Shares Down 3%
16/04	BlinkLab secures A$17.5m to launch autism diagnostic aid
04/04	3,000,000 Performance Rights of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.
04/04	35,000,000 Options of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.
04/04	37,913,846 Ordinary Shares of BlinkLab Limited are subject to a Lock-Up Agreement Ending on 4-APR-2026.
24/03	BlinkLab Launches Pivotal US FDA Trial For AI Smartphone Autism Diagnostic Platform BlinkLab Dx1
24/03	BlinkLab Begins Validation Program For Autism Diagnostic Aid
23/03	BlinkLab Says Autism Test Integrated Into Morocco's Nationwide Autism Screening Program, Shares Fall 4%
18/03	BlinkLab requests trading halt pending national Autism Screening Program announcement
13/03	BlinkLab Partners With US-Based Non-Profit Organization; Shares Up 3%
24/02	BlinkLab Limited Reports Earnings Results for the Half Year Ended December 31, 2025
12/02	BlinkLab Adds Clinical Site For Autism Diagnostic Test Pivotal US Regulatory Trial, Shares Fall 4%
18/12	BlinkLab says Henk-Jan Boele appointed as managing director
17/12	Blinklab Limited Announces Executive and Board Changes
13/11	BlinkLab Says Illinois Medical Center Joins US Clinical Trial for Autism Diagnostic Test
09/11	Patrys Limited Announces Management Changes, Effective 10 November 2025
22/10/25	BlinkLab Completes US Pilot Study for Autism Diagnostic Test
20/10/25	Blinklab requests trading halt pending pilot results